Registered Nurse in Grove Hill, AL Accepting Medicare
6 Registered Nurse nurses found. Showing 1 - 6
 Mr. Mark Anthony Lynn Jr., R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 926 Carter Drive, Grove Hill, AL 36451 Phone: 251-275-4135 Fax: 251-275-2862 |
 Tonya Kaye Hinote, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 Carter Dr, Grove Hill, AL 36451 Phone: 251-575-4203 |
Latasha R Burroughs, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 Carter Drive, Grove Hill, AL 36451 Phone: 251-275-4135 |
Javara Quensha Foster, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 Carter Dr, Grove Hill, AL 36451 Phone: 251-575-4203 Fax: 251-575-9459 |
Bessie King, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 926 Cater Drive, Grove Hill, AL 36451 Phone: 251-275-4135 |
Jessica Ellington, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 Carter Dr, Grove Hill, AL 36451 Phone: 251-575-4203 Fax: 251-575-9459 |
News Archive
Scientists identify novel way of synthesising promising new antibiotic
A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol. By expressing the genes involved in the production of pleuromutilin in a different type of fungus, the researchers were able to increase production by more than 2,000 per cent.
Rizer XL's male enhancement formula increases sexual desire, pleasure and performance
Increasing pressure on men to perform sexually and higher expectations of men's sexual performance from women has led to an astounding rise in sales, says Rizer XL, the leading provider of premium male enhancement pills.
Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).
Stop TB Partnership's new initiative to increase access to two new life-saving TB medicines
The Stop TB Partnership's Global Drug Facility (GDF) will announce a new initiative to increase access to bedaquiline and delamanid - the two new life-saving medicines recently approved for the treatment of multi-drug resistant tuberculosis (TB). The GDF will share how it is expanding existing and developing new public-private partnerships to expedite and maximize access to these two critical medicines.
Breakthrough improves effectiveness of tuberculosis vaccine
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.
› Verified 1 days ago